NCT06447285Not yet recruiting
Early, Objective Detection of Autism.
Source: ClinicalTrials.gov · Last updated 7 Jun 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
1- To test the hypothesis that using the SensoDetect Brainstem Evoked Response Audiometry (BERA) technology may be an effective support tool for pediatricians to detect autism.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 300 (estimated)
- First submitted
- 19 May 2024
- Start date
- 29 May 2024
- Primary completion date
- 1 Jun 2027
- Lead sponsor
- SensoDetect
- Diseases
- Autism
- NCT number
- NCT06447285
What you commit to
- Study type: Interventional
- Planned participants: 300
- From 29 May 2024 to the primary completion date, 1 Jun 2027
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Hearing impairment
- Down syndrome
Other
- Cerebral Palsy
- Significant brain damage Intellectual disability.
Who the study is looking for
- \- All patients attending the clinic of Autism.
Criteria the registry did not label
- Phase I:
Age in the registry: 3 years to 8 years · Sex: All · Accepts healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.